ITRI Joins Forces with Thailand's National Science and Technology Development Agency to Promote Taiwan-Thailand Industries' Green Transformation"ITRI – NSTDA Joint Seminar" to be Held on February 27
Everest Medicines' Licensing Partner Venatorx Pharmaceuticals Announces Publication of Positive Results from Cefepime-Taniborbactam's Phase 3 CERTAIN-1 Study in New England Journal of Medicine
–Cefepime-taniborbactam was superior to meropenem for the composite efficacy endpoint with composite…